An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
Clinical trial NCT01332513 · COMPLETED
Trial details
- NCT number
- NCT01332513
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-10
- Primary completion
- 2011-05-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.